INTRODUCCIÓN WP4

Interventional Studies to optimize treatment of hepatitis C and B, including pharmacokinetics,pharmacoeconomics and resistance. Diagnosis, prevention and management of sexually transmitted infections and other pathogens

Asset Publisher

RIS-HEP20. ZepaLive Study.

Study to assess routine clinical practice results of Elbasvir/Grazoprevir treatment in HCV infected patients with injecting drug use during the treatment with opioid agonists: a national multicentre retrospective observational cohort study in Spain. 
 

Leader Researcher: Juan Macías.

Sponsor: Without sponsors.

Status: Ongoing.

RIS-HEP19. RIS-HEP19 Study.

Study to assess long-term evolution of hepatic steatosis and associated metabolic disorders in HIV infected patients under antiretroviral therapy. 
 

Leader Researcher: Luis M. Real, Juan Macías.

Sponsor: Without sponsors.

Status: Ongoing.

RIS-HEP14. RIS-HEP14 Study.

Study to assess relapse rates of 8 weeks duration treatments with DAA in HCV infected patients vs HIV/HCV coinfected patients 
 

Leader Researcher: Juan A. Pineda, Juan Macías.

Sponsor: Without sponsors.

Status: Ongoing.

RIS-HEP12. RIS-HEP12 Study.

Study to assess efficacy and safety of Sorafenib in the hepatocarcinoma treatment in HIV infected patients under real conditions of use.
 

Leader Researcher: Nicolás Merchante.

Sponsor: Without sponsors.

Status: Completed.

RIS-HEP13. RIS-HEP13 Study.

Study to assess the impact of HIV coinfection in the development of liver complications in HCV chronically infected patients achieving sustained virological response with direct-acting antivirals. 
 

Leader Researcher: Juan Macías, Juan A. Pineda.

Sponsor: Without sponsors.

Status: Ongoing.

RIS-HEP08. RIS-HEP08 Study.

Study to assess the evolution of HIV infected patients undergoing liver transplantation.
 

Leader Researcher: José M. Miró.

Sponsor: Without sponsors.

Status: Ongoing.

RIS-HEP09. RIS-HEP09 Study.

Study to analyse changes in the hepatic steatosis after shifting to Raltegravir in HIV infected patients.  
 

Leader Researcher: Juan Macías, Juan A. Pineda.

Sponsor: Juan Macías.

Status: Completed.

RIS-HEP07. RIS-HEP07 Study.

Study to assess efficacy and safety of direct-acting antivirals in HCV/HIV coinfection treatment under real conditions of use.
 

Leader Researcher: Juan A. Pineda.

Sponsor: Without sponsors.

Status: Recruiting.

RIS-HEP03 GESIDA 3603c. RIS-HEP03 GESIDA 3603c Study.

Study in cured HCV patients with former HCV/HIV coinfection to assess changes in inflammation, endothelial damage, immune activation and preclinical arteriosclerosis.
 

Leader Researcher: J Gonzalez, J Berenguer.

Sponsor: Fundación SEIMC-GESIDA.

Status: Ongoing.